[1]
Sayani, A.P. et al. 2014. Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada. Canadian Urological Association Journal. 8, 1-2 (Jan. 2014), e1–7. DOI:https://doi.org/10.5489/cuaj.755.